Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group (Q43582734)
scientific article published in May 2001
Language:
(P31) (Q13442814)
(P50) (Q42388605)
(Q37842284)
(Q87710572)
(P304) 870-877
(P407) (Q1860)
(P433) 7
(P478) 37
(P577) Tuesday, May 1, 2001
(P921) (Q42824440)
(Q18936)
(P1433) (Q332260)
(P1476) "Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group" (language: en)
(P2093) Judson I
Harris M
van Hoesel Q
le Cesne A
van Oosterom AT
Kamby C
Hermans C
Whittaker J
Donato di Paola E
Verweij J
Nielsen S
(P2860) (Q70524830)
(Q33488674)
(Q36288113)
(Q59081256)
(Q36742644)
(Q39458073)
(Q59289264)
(Q40651587)
(Q68778289)
(Q34729354)
(Q36115868)
(Q34504714)
(Q28251216)
other details
description scientific article published in May 2001

External Links